Novo Nordisk A/S (CPH:NOVO.B)
Denmark · Delayed Price · Currency is DKK 247.05
+0.05 (0.02%)
Mar 13, 2026, 4:59 PM CET
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 1.1 trillion as of March 13, 2026. Its market cap has decreased by -62.37% in one year.
Market Cap
1.10T
Enterprise Value
1.20T
Revenue
309.06B
Ranking
n/a
PE Ratio
10.73
Stock Price
247.05
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 46.00B to 1.10T, an increase of 2,285.68%. That is a compound annual growth rate of 11.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 1.10T | -24.06% |
| Dec 30, 2025 | 1.45T | -47.87% |
| Dec 30, 2024 | 2.77T | -10.93% |
| Dec 29, 2023 | 3.11T | 46.89% |
| Dec 30, 2022 | 2.12T | 26.50% |
| Dec 30, 2021 | 1.67T | 69.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genmab | 104.68B |
| Coloplast | 100.74B |
| ALK-Abelló | 46.40B |
| Demant | 39.67B |
| H. Lundbeck | 36.45B |
| Ambu A/S | 19.06B |
| Zealand Pharma | 18.94B |
| Bavarian Nordic | 14.07B |